MedCity News
APRIL 25, 2025
Technology has the power to revolutionize treatment, make it more widely available, provide additional patient insight, and ultimately, alleviate the strain on our already stressed healthcare system. The post Community-Driven Digital Solutions Can Transform Addiction Treatment and Ease the Burden on the Healthcare System appeared first on MedCity News.
PharmaVoice
APRIL 22, 2025
The discoveries also hold potential benefits for patients with other conditions, such as chronic fatigue syndrome.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Evolve Your Success
APRIL 23, 2025
Breaking Barriers: Navigating the Evolving World of Healthcare and Medical Sales. Join Jasper Freeman, Director of National Accounts at SC Pharmaceuticals, as he shares his transformative journey in medical sales. From pioneering the heart failure treatment device, Ferosix, to making groundbreaking strides in home healthcare, Jasper unveils how cutting-edge technology is reducing hospital visits and revolutionizing patient care.
European Pharmaceutical Review
APRIL 21, 2025
For the first time in over ten years, the US Food and Drug Administration (FDA) has approved a new targeted treatment for chronic spontaneous urticaria. Sanofi and Regeneron Pharmaceuticals collaborated to develop Dupixent (dupilumab). Under the FDA’s new authorisation, the therapy is indicated for individuals aged 12 years and over with the chronic inflammatory skin disease, who still experience symptoms despite taking histamine-1 (H1) antihistamine medication.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MaBiCo
APRIL 24, 2025
Complacency: The Silent Killer of Sales In the high-stakes world of sales, where numbers matter and performance drives success, theres a subtle but dangerous threat lurking beneath the surface: complacency. It rarely announces its arrival. It creeps in silently, often disguised as stability or satisfaction, but its impact can be devastatingboth on individual performance and organizational success.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaVoice
APRIL 21, 2025
Five GLP-1 products will collectively bring in $470 billion by 2030, and the market leaders are working to hold back competition.
Pharma Marketing Network
APRIL 24, 2025
Introduction Artificial Intelligence (AI) is no longer just a futuristic concept in pharmaceutical marketingits the present and future. In 2025, AI-powered pharma marketing is transforming how companies engage healthcare professionals (HCPs), patients, and stakeholders. With evolving compliance requirements and rising demand for personalization, pharma marketers are adopting intelligent platforms to stay ahead.
European Pharmaceutical Review
APRIL 25, 2025
The largest clinical trial investigating a treatment for bronchiectasis has demonstrated a statistically significant reduction in the occurrence of pulmonary exacerbations.Findings from the Phase III ASPEN study of brensocatib could provide future promise for patients, as there are currently no approved treatments for the chronic inflammatory pulmonary disease.
PM360
APRIL 21, 2025
Q. As your company is part of the ecosystem which represented the fourth largest career path vertical for MIT Sloans Class of 2023 , clearly there is interest in students entering this arena. How can the MIT education be applied to firms at the intersection of engineering, healthcare and management? ( Tina Tianning Yu): With the global medical devices market size projected to increase from last years approximate $518 Billion to $886 Billion in 2032 , the sector is a fertile ground for graduates
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
MedCity News
APRIL 25, 2025
Caribou Biosciences restructuring narrows the biotechs focus to two off-the-shelf cell therapies for blood cancers, whose key data readouts have been pushed out to the second half of 2025. Its the CRISPR-editing companys second cash-saving restructuring in the past year. The post CRISPR Biotech Caribou Trims Pipeline and Cuts 32% of Staff to Focus on Two Cancer Cell Therapies appeared first on MedCity News.
PharmaVoice
APRIL 21, 2025
SpringWorks Therapeutics and the Children’s Tumor Foundation salvaged a shelved asset for neurofibromatosis and got it over the regulatory finish line.
Pharma Marketing Network
APRIL 22, 2025
Introduction Pharma brands are rethinking their digital engagement strategies in 2025. With regulatory scrutiny evolving and audience expectations shifting, social media marketing plans have become a central focus for companies looking to maintain trust while expanding reach. Social platforms are no longer just optional toolsthey’re vital channels for HCP and patient engagement.
European Pharmaceutical Review
APRIL 21, 2025
Quality-by-design (QbD) is a systemic risk-management strategy that facilitates the production of safe and consistent drugs. As pharma and biotech companies move towards more complex medicines, it is critical they have contract development and manufacturing organisation (CDMO) partners who can implement QbD principles while maintaining the accelerated timelines required for competitive business.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
PM360
APRIL 23, 2025
Partnership strengthens Havas innovation strategy, providing premier access to the fastest-growing AI engagement platform in life sciences. Havas today announced a strategic investment and partnership with Ostro, the trailblazing AI-powered engagement platform built for the life sciences industry. In a world where consumers and healthcare providers (HCPs) are bombarded with information about new healthcare treatment options, Ostro provides a personalized healthcare journey and serves as the AI i
MedCity News
APRIL 24, 2025
Etiomes precision medicine approach introduces a temporal component to treating disease drugs developed specifically to treat disease at particular points in time even before symptoms show. The Flagship Pioneering startups approach offers the potential to prevent disease; in cases where disease is already present, Etiome aims to halt or even reverse it.
PharmaVoice
APRIL 25, 2025
A look at the government’s far-reaching rollback in research grants so far.
Pharma Marketing Network
APRIL 23, 2025
Introduction In 2025, the pharmaceutical industry finds itself in the midst of a digital transformation, where trust and personalization are more important than ever. Pharma brands are no longer competing solely on productstheyre competing on relationships. As a result, customer engagement strategies have taken center stage in shaping how companies connect with healthcare professionals (HCPs), patients, caregivers, and stakeholders.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
European Pharmaceutical Review
APRIL 24, 2025
Researchers have suggested a potential approach to measure the effective work of powder adhesion between particle-surface contact, using the drop test method. Specifically, they assessed irregularly shaped ibuprofen powders and spherical aluminium-alloy powders.Citing current adhesion challenges during tablet manufacturing, the authors highlighted the need to numerically predict if a new formulation may exhibit adhesion problems earlier [in R&D].
Scott Burrows
APRIL 25, 2025
Competition can be intense. Whether its a rising competitor gaining momentum, an industry shift diminishing demand for your services, or a long-time rival slowly edging you out, its easy to feel cornered. But setbacks dont have to dictate your future. Instead, they can propel you forward. Rather than feeling trapped by competition, use it as a catalyst for growth, innovation, and renewed purpose.
MedCity News
APRIL 24, 2025
The time to innovate is now. By embracing transformative solutions, insurers and employers can not only address systemic challenges but also create a future where healthcare is equitable and sustainable. The post How Health Insurers Are Embracing Technology to Serve Real People appeared first on MedCity News.
PharmaVoice
APRIL 24, 2025
A new AI-based company launched by the prolific venture capital firm Flagship Pioneering marks another platform approach in forward-thinking early science.
Pharma Marketing Network
APRIL 25, 2025
Introduction In the age of digital disruption and evolving patient expectations, does Referral Marketing hold any real value in the pharmaceutical space? Think about this: when a friend recommends a restaurant, youre far more likely to try it. The same psychology applies in healthcare, though with significantly higher stakes. As pharma brands like Ozempic and Dupixent seek to establish deeper connections with prescribers and patients, referral-based strategies are increasingly being tested acros
pharmaphorum
APRIL 22, 2025
Roche will spend $50bn on manufacturing and R&D facilities in the US, with a pledge to export more medicines from the US than it imports
Pharmaceutical Technology
APRIL 22, 2025
Roche is set to invest $50bn in pharmaceuticals and diagnostics in the US over the coming five years to bolster its presence in the country.
MedCity News
APRIL 21, 2025
Even the most promising medical advancements struggle to take off in real-world settings without clinician buy-in. Here are some key factors that affect clinician adoption and ways healthtech companies can better position their innovations for success. The post Clinician Adoption: How HealthTech Can Overcome Key Barriers appeared first on MedCity News.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
PharmaVoice
APRIL 22, 2025
As the diabetes and weight loss market booms, more collaboration between pharma and medtech could help patients get the most out of injectable drugs.
Pharma Marketing Network
APRIL 25, 2025
Introduction In a rapidly evolving healthcare landscape, how can your Pharma Network stay ahead of the curve? As pharmaceutical brands face an unprecedented wave of digital transformation, strategic innovation, and shifting regulatory landscapes in 2025, optimizing your network has never been more critical. Much like upgrading an outdated GPS for an unknown journey, refreshing your pharma connections will determine whether your brand thrives or struggles in the new era.
PharmaTimes
APRIL 22, 2025
The SHIELD-Utah study compared Novavaxs vaccine to Pfizer/BioNTech mRNA 2024 to 2025 vaccine
Expert insights. Personalized for you.
272 
Let's personalize your content